News | April 21, 2022
Agilent joins the National Institute for Innovation in Manufacturing to advance biomanufacturing
Support for biologics manufacturability and Industry 4.0 initiatives
Support for biologics manufacturability and Industry 4.0 initiatives
Support for bioprocess, cell and gene therapy, and industry 4.0 initiatives
The facility will enable research initiatives in analytical chemistry, biopharmaceuticals, and life sciences
Revenue of $1.67 billion represents 8% reported growth; and up 9% on a core(basis.
Agilent will integrate the technology into its lab informatics platforms, enabling customers to automate GC/MS data analysis
Optimized for pharma/biopharma to deliver a deeper understanding of cellular function
Victor Chang Cardiac Research Institute (VCCRI) researcher recognized for his influential work on cardiovascular disease
New bioinformatic workflow advances analysis capabilities for whole-exome assessment and interpretation
Agilent Technologies Inc. announced the contribution of Agilent AriaMx Real-Time qPCR instruments to five research hospitals in India to support their COVID-19 initiatives and help them serve the community at large
These initiatives will harness top scientific talent and advanced AI technologies to develop new ways to slow the rise of drug-resistant infections
Subscribe To Our Newsletter & Stay Updated
